IGEM:IMPERIAL/2006/project/popsblocker/Design

• Specifications
• Design
• Modelling
• Implementation
• Validation

Registry

Two devices are required:

• 1) A complementary sequence for a reporter with loxP sites either side
• 2) Cre recombinase under the control of a promoter

The LoxP device J37027 can be found here

Cre recombinase device in registry J37030

Design choices

Design of primers and method of construction

Proposed Implementation of Cre-LoxP system

Discussion over design

Cre recombinase

Cre recombinase device in registry J37030

Sequence and primers here

There is one further step that we need to take if we want to successfully incorporate this system into the whole system. The plasmid containing the Cre enzyme coding region will be going into the prey cell. However the prey cell will already contain the main coding plasmid, which has ampicillin resistance. Therefore to ensure that the second plasmid is taken up into the cell as well, we need to swap plasmids by ligation. Ligating into a kanamycin resistant plasmid is probably our best bet. We could do this after the device has been constructed in the ampicillin resistant plasmid.

LoxP sites

The two LoxP sites that we are going to use are Lox66 and Lox71 - mutant LoxP sites

Sequences - Lox66 and Lox71

Alterations to Cre-Lox System

Further Reading

• Cre recombinase: The universal reagent for genome tailoring
• Cre recombinase-mediated inversion using lox66 and lox71: method to introduce conditional point mutations into the CREB-binding protein

INPUTS	biological component	comments
input 1	bla bla bla	bla bla bla
input 2	bla bla bla	bla bla bla
input 3	bla bla bla	bla bla bla
OUTPUTS	biological component	comments
output 1	bla bla bla	bla bla bla
output 2	bla bla bla	bla bla bla

Open issues

• The parts are not available in the registry however, which means that we would have to make them.
• The loxP sites are around 20 bases in length and so sequences can be be worked out and bought fairly easily.
• The Cre recombinase site is around a kilobase in length. However we have been able to obtain the enzyme from one of the labs, and as it is isolated in a plasmid, this will make it much simpler for us to incorporate it into our design.
• The Cre recombinase will also need a promoter - perhaps we could use one such as lacI? (we need to find out whether IPTG has any effect on other promoters though)
• With all the parts available, we estimate that the length of time for implementation should be under a week.